 |
Hanmi Pharm |
[Alpha Biz= Reporter Kim Jisun] Chairwoman Song Yeong-sook and Vice Chairwoman Lim Ju-hyun of Hanmi Pharmaceutical Group have allied with Shin Dong-guk, Chairman of Hanyang Precision, who is the largest shareholder, to reclaim management control from the Lim brothers, Jong-yoon and Jong-hoon.
On the 3rd, Hanmi Science announced that Shin Dong-guk, the largest individual shareholder, signed a stock purchase agreement to acquire a 6.5% stake (4,444,187 shares) from Chairwoman Song and Vice Chairwoman Lim. They also entered into an agreement to exercise voting rights jointly.
Chairman Shin, who previously supported the Lim brothers, has now joined forces with the mother-daughter duo.
Together, Chairman Shin and the Song-Lim family now hold approximately 35% of the shares.
Additionally, this agreement enables Chairwoman Song and Vice Chairwoman Lim to secure funds for inheritance tax payments.
AlphaBIZ Kim Jisun(stockmk2020@alphabiz.co.kr)
